VC Funding in Life Sciences Plummets in Q2, Report Finds | GenomeWeb

NEW YORK (GenomeWeb News) – Venture capital investments into the life sciences dropped sharply in the second quarter compared to a year ago, according to a report this week from PricewaterhouseCoopers and the National Venture Capital Association.

VC funding into the life sciences sector, which includes biotechnology and medical devices, was down 39 percent year over year in dollar amounts and down 22 percent in the number of deals. A total of $1.4 billion was invested into 174 life science deals in the second quarter, the report said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: certain genes repressed during memory formation, analysis of genomes from single neurons, and more.

NASA plans to test whether DNA sequencing studies can be conducted in microgravity.

Congress passes a continuing resolution to keep the US federal government funded through mid-December.

The Human Genome Project was launched 25 years ago, and at Nature, Francis Collins, James Watson, and Eric Green look back at the lessons learned.